>>> What to look at today -1st of Nov. 2017

Dow +0.12% S&P +0.09% NAsdaq +0.43% Russell +0.78%
US Market closed on new record level. SPX closed the month up +2.2%, was 7th consec monthly gain for index, also was best monthly gain since Feb (when rallied +3.7%). SPX now up 11 of last 12months. NDX up up and away (Semis higher on Bitcoin +4% and Samsung CAPEX call). Hard Drives benefited on SMASUNG and APPLE and chain higher as APPLE up another +1.4%. Crude strength helped Energy (API and slew of EPS today). Brent touched $61 today. Homes better after yday M&A, and today WILLIAM LYON HOMES UP 10.9% helped (earnings). Paper and Internets higher also on earnings. Consumers smoked again on UNDER ARMOUR DOWN 23.8% on warning. Steels hit hard on AK STEEL, DOWN 21.5% on earnings. Now focus shifts to FOMC and 39 of SPX due to report today. Us after Hours  QLYS +9%, X +8% higher and EVHC -29%, DDD -15%, WNC -10%, RGR -9%, CHKP -7%, PAYC -6% lower following earnings/guidance. Asian Market higher following US Move. Reflation trades have turned around with regional yields tracking higher alongside major banks and the dollar. CHINESE MARKETS are posting modest gains, extending their recovery from early week volatility that accompanied a spike in bond yields. The PBoC made no net change to liquidity following recent injections. The Caixin PMI confirmed China’s manufacturing sector remained in expansion last month despite the impact of government-ordered curbs on pollutive firms. THE NIKKEI is leading regional gains with the yen down ~1% from Tuesday's high against the dollar. Positively received earnings from SONY and PANASONIC have helped to underpin sentiment.

Nikkei +1.86% Hang Seng +0.87% Shanghai +0.01% Shenzen +0.03%

Eur$ 1.1640 CNH 6.6183 CNY 6.6182 JPY 113.85 GBP 1.3285 CHF 0.9984 RUB 58.2250 WTI$ 54.69 +0.57%

S&P +0.18% EuroStoxx +0.33% Dax +0.78% (Catching Up yest. move) SMI +0.29% FTSE +0.28%

Macro :
- U.K. Hints at Compromises on Brexit Bill as Talks Resume
- Greece Is Said to Plan Debt-Swap Exercise Worth EU30 Billion

Keep an eye on :
- ASMI NA : ASMI 3Q a ‘Mixed Bag,’ Revenue Guidance Is Good: Morgan Stanley
- BEN FP : Beneteau FY Earnings Beat Estimates as Yacht Earnings Surge
- BLT LN : BHP Executive Says Path to Rail Automation Has Begun in Iron Ore
- BPM PL : Banco BPM and Cattolica Mutually Extend Exclusivity Period
- DTE GY : Sprint, T-Mobile’s Last-Ditch Talks Are Said on Life Support
- EPR NO : Europris Third Quarter Revenue Misses Lowest Estimate
- ELIOR FP : Elior Says Fontana Appointed Interim CEO, Cojan Named Chairman
- EO FP : Faurecia In Joint Venture With BYD For Seating Solutions
- GTO NA : Gemalto to Buy Back Up to ~EU1.13B of Shares Over Next 12 Months
- NK FP : Imerys 9M Net EU268m; Confirms FY Outlook
- LUPE SS : Lundin Petroleum Third Quarter Ebitda Beats Estimates
- MHG NO : Marine Harvest Third Quarter Net Income Beats Estimates
- NRE1V FH : Nokian Renkaat 3Q Op. Profit Beats Highest Est., Margin Improves
- NOVOB DC : Novo Nordisk Sees Full Year Ebit 0% To +3%, Saw -3% To +1%
- SBRY LN : Sainsbury’s Starts Record Label to Tap Vinyl Demand: FT
- SU FP : Schneider Is Said to Lead Bidding for L&T Electric Unit: Mint

>>> Europe : Brokers Upgrades & Downgrades - 1st of Nov. 2017

>>> Up
* ABB Raised to Buy at Kepler Cheuvreux, PT CHF28
* Avanza Raised to Buy at SEB Equities, PT SEK355
* G4S Raised to Buy at Jefferies, PT 330p
* InterContinental Raised to Outperform at Credit Suisse
* Neinor Raised to Buy at BPI, PT EU21.75
* Nyrstar Raised to Buy at ING, PT EU8.50
* Telenet Raised to Hold at Kepler Cheuvreux, PT EU60
* Unicaja Banco Raised to Hold at Kepler Cheuvreux, PT EU1.23

>>> Down
* Debenhams Cut to Sell at Liberum, PT 40p
* Hilton Food Cut to Hold at Peel Hunt
* LafargeHolcim Cut to Hold at HSBC, PT CHF60
* Red Electrica Cut to Sell at Berenberg (Double Dwg)

>>> Initiation
* Clinigen New Hold at Berenberg, PT GBP12
* Unicaja Banco New Hold at Ahorro Corporacion, PT EU1.18
* Warehouse Reit New Buy at Peel Hunt, PT 118p

>>> Call

>>> Asian Update

Asia Mid-Session Update: Markets continue higher, metals also gaining ahead of Fed and BOE meetings

***Asia Summary***
-Asian equity markets opened generally higher, tracking the gains seen in the New York session.
-Honda has gained over 1%, ahead of its earnings report which is expected later today. Nissan and Toyota are also trading higher. Electronic parts manufacturer Murata Manufacturing has declined by over 7%, after reducing its profit forecast. Australian building products manufacturer, CSR, has declined by over 5% after releasing its H1 results and guidance.
-In the tech sector, Sony has gained over 9%, as the company reported better than expected Q2 results and raised its FY outlook. Shares of Softbank have rebounded by over 0.5%, after dropping over 4% during the prior session.
-Chip equipment firm, Tokyo Electron has also gained over 9% after raising its FY forecast. In South Korea, Samsung Electronics is higher by over 3%. The company has added on to the gains seen in the prior session when it announced its financial results, shareholder return plan and management changes. Hynix has gained over 2%. During yesterday’s New York session, chipmaker Micron gained over 6% on above average volume.
-Australian retailer Woolworth’s has risen by over 1%. During the prior session, the company’s shares rose by over 2% after it reported growth in its quarterly sales. Shares of Harvey Norman are higher by over 6% after Australia’s securities regulator (ASIC) said that it would not make any further inquiries related to the way the company consolidates its sales figures. Department store Myer Holdings has declined by more than 4%, after reporting a decline in Q1 sales and updating some of its medium-term targets.
-Amid the gains being seen in oil prices, Australian energy producer Santos has risen by over 1%, while Woodside Petroleum is also trading higher. Oil Search has declined by over 2% after agreeing to pay $400M to acquire assets in Alaska’s North Slope.
-In the steel sector, Kobe Steel has risen by over 3%. On yesterday’s session, the company’s shares gained over 3% amid the release of its most recent earnings report. Following the US equity close, shares of US Steel rose by over 7% on better than expected quarterly earnings.
-Mega banks in Japan are generally higher with shares of Mitsubishi UFJ up over 0.7%. In Australia, the ‘big four’ banks are also trading generally higher. In China, insurers are trading higher, with shares of China Life up by over 2% and PICC Property P&C has gained over 6%. The Hang Seng Property Index has risen over 0.5%, as shares of Vanke are higher by more than 3%.
-Hong Kong listed retailer Tapestry, formerly Coach, said it plans to withdraw its HK listing amid low trading volumes. Earlier in the week, miner Glencore made a similar announcement.
-China’s Oct Caixin manufacturing PMI met market expectations and was unchanged from the prior figure.
-Oct PMI data from Indonesia, Malaysia, Taiwan, Thailand, Vietnam and South Korea declined versus the prior month.
-In South Korea, the Oct CPI and Trade Balance data also missed expectations. On yesterday’s session, Bank of Korea (BOK) Gov Lee said while Q3 GDP growth was ‘good’, he was still monitoring to see if growth continued for a rate hike.
-In Japan, there has been renewed speculation in the press that PM Abe is expected to request an extra budget and that Kuroda is likely to be named to another term as governor of the Bank of Japan (BOJ).
-USD/JPY has gained over 0.1%, ahead of the later today US Fed decision. The Kiwi has risen by over 0.7% after Q3 jobs data beat expectations.
-Looking ahead, US House Tax Committee Chairman Brady said the text of the Republicans tax bill will be released on Thursday. He had previously said there was ‘no announcement of [a] change to Wed’s release for the tax bill.’
-Japanese companies expected to report earnings later today include ANA Holdings, Hino Motors, IHI Corp, JFE Holdings, Japan Tobacco, KDDI, Mitsubishi Gas Chemical, Mitsui Chemicals, NSK, Rohm, Shinsei Bank, Takeda Pharmaceuticals, Ube Industries and Yamaha.

***Key economic data***
- (NZ) NEW ZEALAND Q3 UNEMPLOYMENT RATE: 4.6% V 4.7%E, EMPLOYMENT CHANGE Q/Q: 2.2% V -0.2% PRIOR; Y/Y: 4.2% V 3.1% PRIOR
- (KR) SOUTH KOREA OCT CPI M/M: -0.2% V 0.0%E; Y/Y: 1.8% V 1.9%E; CORE CPI Y/Y: 1.3% V 1.4%E
- (KR) SOUTH KOREA OCT TRADE BALANCE: $7.3B V $8.7BE
- (JP) JAPAN OCT FINAL PMI MANUFACTURING:52.8 V 52.5 PRELIM
- (CN) CHINA OCT CAIXIN MAUFACTURING PMI: 51.0 V 51.0E (weakest pace since June, unchanged from prior)

***Speakers and Press***
Japan
- (JP) BOJ Gov Kuroda being considered for another term - Japan press
- (JP) BOJ Gov Kuroda: Reiterates that domestic economy is expanding moderately; downside risks to prices are larger - post rate decision press conference (yesterday)
- (JP) Japan PM Abe expected to request extra budget at today's cabinet meeting – Kyodo
- (JP) Japan FIn Min Aso: Current economic trends aren't 'bad'

Korea
- (KR) US said to pursue direct diplomacy with North Korea - financial press
- (KR) South Korea President Moon seeking approval for 2018 budget - speaking at parliament

China/Hong Kong
- (CN) PBOC Adviser: See conditions for additional FX reforms - Chinese press

US
- (US) Follow Up: House GOP said to delay rolling out tax bill until Thursday - US financial press

***Asian Equity Indices/Futures (00:00ET)***
- Nikkei +1.3%, Hang Seng +0.5%; Shanghai Composite +0.2%; ASX200 +0.5%, Kospi +1.1%
- Equity Futures: S&P500 +0.2%; Nasdaq100 +0.3%, Dax +0.7%; FTSE100 +0.2%

***FX ranges/Commodities/Fixed Income (00:00ET)***
- EUR 1.1655-1.1629; JPY 113.94-113.61; AUD 0.7669-0.7648;NZD 0.6914-0.6883
- Dec Gold +0.0% at $1,270/oz; Dec Crude Oil +0.4% at $54.62/brl; Dec Copper +1.1% at $3.14/lb
- (AU) Australia sells A$900M in 2.25% 2028 bonds; avg yield 2.7273%; bid-to-cover 5.3x
- USD/CNY *(CN) PBOC SETS YUAN REFERENCE RATE AT 6.6300 V 6.6487 PRIOR
- (CN) PBoC OMO: Injects CNY240B combined in 7-day, 14-day and 63-day reverse repos v CNY300B prior; Net injection CNY0B v CNY80B prior
- (CN) China MOF sells 1-year bonds at 3.54%, bid-to-cover 2.19x; Sells 10-year at 3.82%; bid-to-cover 4.16x

***Equities notable movers***
Australia/New Zealand
- WLD.AU Reports first beef shipment to China after lifting of ban; +12.5%

Japan
- 6758.JP Reports H1 Net ¥211.7B v ¥26.0B y/y; Op ¥361.8B v ¥ 101.9B y/y; Rev ¥3.92T v ¥3.92T y/y; Raises FY17/18 guidance; +10%
- 2206.JP Reports H1 Net ¥11.4B v ¥11.6B y/y; Op ¥15.5B v ¥16.4B y/y; Rev ¥187.6B v ¥186.2B y/y; -10%

Korea
- 006400.KR Reports Q3 (KRW) Net 134.9B v -35.2B y/y, Op 60.2B v -110.4B y/y, Rev 1.71T v 1.63Te; +8%

>>> US After Hours Summary: QLYS +9%, X +8% higher and EVHC -29%, DDD


After Hours Summary: QLYS +9%, X +8% higher and EVHC -29%, DDD -15%, WNC -10%, RGR -9%, CHKP -7%, PAYC -6% lower following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: BBOX +11.1% (light volume), QLYS +8.7%, BGFV +8%, X +7.6%, NFX +7.2%, BGS +6.9%, KAR +4.4% (also increases quarterly dividend to $0.35/share, prior $0.32/share), BBG +3.9%, MOD +3.6%, SYX +3.2%, CHRW +1.6%, MASI +1.4% (light volume), TEX +0.6%

Companies trading higher in after hours in reaction to news: AVGR +18.4% (confirms received 510(k) clearance from the FDA for modifications to the company's Pantheris Lumivascular atherectomy system), WPRT +8.4% (BRC Gas Equipment was awarded a competitive tender bid by Algeria's National Company for Petroleum Products Marketing and Distribution), PTI +6.4% (ticking higher; initiates a 'strategic prioritization to focus resources on the research and development of its cystic fibrosis programs'), TROV +5.6% (withdraws Registration Statement on Form S-3 initially filed on September 29, 2017), CARA +2.5% (plans to present late-breaking data at the American College of Rheumatology ACR/ARHP Meeting November 3-8)

Select steel names are higher on light volume after U.S. Steel (X) jumps ~8% on earnings/guidance: AKS +3.3%, NUE +0.3%

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: EVHC -29.1%, DDD -15.3%, WNC -10%, RGR -8.7%, CHKP -7.4%, PAYC -5.7%, HCLP -5.7%, FORM -5.5%, QUAD -4.8%, IPHI -4.2% (light volume), SENS -4.1% (light volume), COTV -3.3% (also announces that Bradley Ferguson has been named Senior Vice President and Chief Financial Officer of the company, effective November 6), PZZA -2.9%, EA -2.5%, LDL -2.1% (light volume)

Companies trading lower in after hours in reaction to news: MRNS -7.6% (files $200 mln mixed securities shelf offering), SSYS -5.9% and XONE -3.6% (following DDD results), BLRX -5.8% (entered into $30 mln at-the-market sales agreement with BTIG), PRKR -2.7% (files for 4 mln share common stock offering by Aspire Capital; company may receive proceeds of up to $20.0 million pursuant to common stock purchase agreement), SYMC -2.5% and FEYE -0.7% (following CHKP results), AOBC -2.3% (RGR sympathy), CDXC -1.5% (files for 1,965,417 share common stock offering by selling stockholders), PHG -0.7% (pulling back on light volume; District Court enters permanent injunction against Philips North America and two executives to limit distribution of adulterated external defibrillators), ATVI -0.3% (following EA results)

>>> US Close Dow +0.12% S&P +0.09% NAsdaq +0.43% Russell +0.78%

Closing Market Summary: Slim Victory Leaves Nasdaq at Record High

Equities ticked higher on Tuesday, ending the session near their opening marks. The Nasdaq (+0.4%) outperformed both the S&P 500 (+0.1%) and the Dow (+0.1%), finishing at a new record high. Meanwhile, small caps did even better, sending the Russell 2000 higher by 0.8%.

The S&P 500's consumer staples sector (+0.8%) paced Tuesday's advance, thanks in large part to Mondelez International (MDLZ 41.43, +2.13)--the owner of brands like Oreo, Trident, and Chips Ahoy!--and Kellogg (K 62.53, +3.66)--which houses brands like Froot Loops and Pringles. The two companies jumped 5.4% and 6.2%, respectively, after reporting better-than-expected earnings and revenues.

Within the Dow Jones Industrial Average, Intel (INTC 45.49, +1.12) was the strongest component, adding 2.5%, following a Wall Street Journal report that Apple (AAPL 169.04, +2.32) could use the chipmaker's hardware, instead of Qualcomm's (QCOM 51.01, -3.65), in future iPhones and iPads. QCOM shares moved in the opposite direction, losing 6.7%.

As a reminder, Apple and Qualcomm are currently in a legal battle, with Apple alleging that Qualcomm has unfairly used its monopoly position as a manufacturer of baseband processors.

The price of crude oil climbed on Tuesday, helping the S&P 500's energy sector (+0.4%) finish near the top of the sector standings. WTI crude futures finished the session higher by 0.4%, at a price of $54.35/bbl--which marks the commodity's best close since late February. Over the last three weeks, WTI crude has climbed more than 10.0%.

Conversely, health care stocks struggled, with Mylan (MYL 35.71, -2.53) leading the retreat. The pharmaceutical company plunged 6.6% after Bloomberg reported that executive Rajiv Malik is the target of a multi-state investigation into generic drug price collusion. Pfizer (PFE 35.06, -0.09) also underperformed, slipping 0.3%, despite reporting above-consensus third quarter earnings.

The heavily-weighted financial sector (-0.3%) also moved lower, as did the industrials (-0.4%) and consumer discretionary (-0.1%) groups. Within the consumer discretionary space, Under Armour (UAA 12.52, -3.89) was by far the weakest performer, plunging 23.7%, after cutting its outlook for the full year and reporting its first quarterly fall in revenue since going public back in 2005.

Outside the equity market, U.S. Treasuries finished modestly lower, with shorter-dated issues showing particular weakness; the yield on the benchmark 10-yr Treasury note climbed one basis point to 2.38%, while the 2-yr yield jumped three basis points to 1.59%. Meanwhile, the U.S. Dollar Index climbed 0.1% to 94.44.

The Federal Open Market Committee began a two-day policy meeting on Tuesday, but its latest policy directive--which will be released on Wednesday afternoon--is not expected to do much more than set the stage for a December rate hike. The CME FedWatch Tool currently places the chances of a December rate hike at 99.5%.

Reviewing Tuesday's economic data, which included the third quarter Employment Cost Index, the October Chicago PMI, October Consumer Confidence, and the August S&P Case-Shiller Home Price Index:

  • The third quarter Employment Cost Index rose 0.7%, while the consensus expected an increase of 0.6%.
    • The key takeaway is that there was a slight pickup in compensation costs in the third quarter, but not enough to trigger any undue inflation alarm.
  • Chicago PMI for October hit 66.2 (consensus 61.0), up from 65.2 in September.
    • The key takeaway from the report is that manufacturing conditions are strong in the Chicago Fed region, underscored by the New Orders Index hitting its highest level (69.9) since June and the second highest since May 2014.
  • The consumer confidence reading for October increased to 125.9 from the prior month's revised reading of 120.6 (from 119.8). The consensus expected the survey to hit 121.5.
    • The key takeaway from the report is that upbeat attitudes about the current job market factored prominently in the elevated reading, which is a hopeful indication for stronger consumer spending activity.
  • The Case-Shiller 20-city Index increased 5.9% in August.

On Wednesday, investors will receive the weekly MBA Mortgage Applications Index at 7:00 ET, the October ADP Employment Change Report (consensus 215K) at 8:15 ET, the October ISM Index (consensus 59.0) at 10:00 ET, September Construction Spending (consensus -0.2%) also at 10:00 ET, and the latest FOMC policy decision at 14:00 ET.

In addition, auto and truck sales for the month of October will be released throughout the day, and the House is scheduled to release its tax reform bill.

  • Nasdaq Composite +25.0% YTD
  • Dow Jones Industrial Average +18.3% YTD
  • S&P 500 +15.0% YTD
  • Russell 2000 +10.7% YTD

Business Of Fashion : With $2 Billion IPO Under Belt, SMCP Plots China Growth

With $2 Billion IPO Under Belt, SMCP Plots China Growth


As SMCP goes public, BoF speaks to the company's co-founders and chief executive about the affordable luxury giant's trajectory and future ambitions.

PARIS, France — Sisters Judith Milgrom and Evelyne Chétrite are dressed in high-waisted denim, cotton t-shirts and sharply tailored blazers from Maje and Sandro, as they sit down with BoF to discuss the brands they built from scratch and, together, grew into the affordable luxury giant SMCP (Sandro, Maje and Claudie Pierlot), which is set to list on Euronext in Paris on Friday. SMCP's initial public offering values the business at 1.7 billion euros (about $2 billion) at 22 euros per share, trading in the form of promesses d‘actions, a type of share right.

Chétrite founded the “androgynous yet feminine” Sandro back in 1984. Milgrom founded the “modern, active, effervescent” Maje four years later. In 2009, the sisters bought Claudie Pierlot, a younger, more romantic brand, from its namesake owner. Since then, the rise of SMCP, a global juggernaut with 1,223 stores and sales of 786 million euros ($931 million) last year, has been impressive. Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 22 percent to €130 million ($140 million) in 2016.

The company's success is rooted in a formula — like a wave of other French contemporary brands — that blends the affordability and slick, back-end operations of fast fashion with a luxury-like image and customer experience. Each of SMCP's brands has its own Paris atelier and their stores are positioned in high-end spaces on prestigious shopping streets. But speed-to-market is critical: while SCMP brands aren’t operating nearly as quickly as fast fashion giants like Zara, the company can take new items from design to shop floor in about 100 days, about twice as fast as traditional fashion brands (25 new products arrive in stores each week). The company achieves this by sourcing and manufacturing the majority of its clothes in Europe and the Mediterranean and buying others products in Asia, such as cotton t-shirts, that are finished in Europe in accordance to the latest trends.

Affordable pricing or “sensitivity to cost purchase,” in the words of chief executive Daniel Lalonde, is critical. A luxury dress for 3,000 euros may be worn three times at a cost-per-wear of 1,000 euros, while a 300-euro Sandro dress may be worn ten times to work, out at night and across seasons, yielding a cost per wear of 30 euros, he explains in an exclusive interview just days before the IPO.

“What helps is the mixing and matching,” adds Milgrom. “Luxury customers buy our clothes then wear Tank Cartier watches and Dior shoes, in China particularly. It is high quality but at affordable prices, and always on trend. That is why we see a lot of luxury customers in our stores.”

Back when Sandro and Maje started in the 1980s, the brands sold only to department stores and boutiques. The strategy helped the founders understand the product and build awareness of their affordable luxury offering. But nearly 20 years later, they pivoted their approach and launched their own retail stores. Maje opened on the Left Bank in the Sixth Arrondissement in 2002, while Sandro opened in the trendy Marais area of Paris in 2004, ending both brand's reliance on wholesale.

The benefits of the retail-led model were manifold. “We’re allergic to the traditional way of doing wholesale,” Lalonde explained to BoF earlier this year. “Ninety-four percent of our business is done through direct retail [and] there are big, big advantages of being a retail pure player today. You control your distribution, you control your commercial policy, you can replenish the stores quickly. We know what sells right away.”

After two decades of business, Chétrite and Milgrom also sought investment to take their brands global. They found a partner in L Capital, LVMH’s private equity arm, who took a 51 percent stake in the business in 2010 and who, along with private equity firm Florac, were key to SMCP’s understanding of the luxury sector, Chétrite says. As is typical of private equity holding cycles, L Capital’s sold its stake to investment firm KKR in 2013. “They bought the structure to grow,” she says, and were instrumental in the hiring of chief executive Lalonde.

Three years later, after having doubled sales, KKR sold most of its holding to Chinese textile firm Shandong Ruyi, who took a 65 percent stake in the business for 1.3 billion euros including debt, according to a Bloomberg report at the time. While Shandong Ruyi supplies a small amount of fabric for Sandro Homme suits, the investment was not about synergies. The Chinese firm is “a long term investor” says Lalonde, with five members on the board, along with Chétrite, Milgrom, Lalonde and four independent members including Patrizio di Marco, the former chief executive of Gucci. The textile firms knowledge of Asia is most valuable, as SMCP has ambitions to expand heavily in the region.

KKR retained a 9.8 percent stake, which it will cash out with a hefty profit on Friday. When the firm purchased its stake in 2013, SMCP was valued at 650 million euros, versus 1.7 billion euros today. While other co-investors will also exit, Shandong Ruyi will remain a majority shareholder in the company at 55 percent, and the founders and management retain their stake of around 10 percent, worth around 170 million euros.

“If you’re going to make a considerable push into retail and expand your footprint, the IPO has to be around volume and growth,” says John Guy, head of European luxury at Mainfirst Bank. “SMCP have very good brand awareness, but it’s a pure growth story rather than a margin story,” says Guy.

The market remains fiercely competitive, and analysts are cautious about SMCP’s growth on the public market. “The main issue is to find the right pace of development of store expansion for the brand and at the same time keep up the brand desirability in a part of the market in which competition is very high," says Mario Ortelli, head of luxury goods at Sanford C. Bernstein. Opening too many costly stores can compress margins if there is a slow down in sales over time, he adds. And responding to the fashion cycle means there will always be the relentless need for on-trend products.

Firstly, SMCP plans to reduce its 300 million euros debt to cut the high interest rates on the bonds it is are repaying. Then the company has its eyes on China, where Lalonde says it can quadruple the number of stores to equal its presence in France, its largest market, to tap the growing number of middle-class shoppers. Sales growth in affordable luxury outperformed most other sectors last year, driven particularly by Chinese, according to the McKinsey Global Fashion Index.

“Yes, we have that ambition, but as important is our development in Europe, Italy, Spain, Germany and the UK,” Lalonde says, adding that he has plans for openings in Japan and is looking at Latin America and South-East Asia, too. He also aims to grow Sandro Homme from 20 percent to 35 percent of Sandro’s sales in the next 5 years, while also the doubling overall accessories and shoes business to 15 percent.

Over the longer-term, SMCP will also consider purchasing other brands that would “add value to our portfolio,” Lalonde continues. “The vision is to become a global leader in accessible luxury. We are in early stages of growth of all the brands. There’s so much to do, so much runway ahead of us: digital, e-commerce, accessories. We’re just at the beginning of this chapter.”

WWD : CEO Talks: Jean-Claude Biver on Brand Coherence

CEO Talks: Jean-Claude Biver on Brand Coherence
The watch industry maverick stressed the importance of disruption, brand philosophy and listening to younger generations.
By Mimosa Spencer on October 31, 2017

He might describe himself as a whole grain rice kind of hippie, but it’s easier to imagine him in the pulpit.
Tall with broad shoulders, Jean-Claude Biver, the head of LVMH Moët Hennessy Louis Vuitton’s watch division, cuts an imposing figure. He is credited with rescuing the traditional watchmaking industry in the Eighties by reviving Blancpain, a brand laid to waste by competition from quartz technology. Biver also boosted the fortunes of Omega, ushering in the era of celebrity brand ambassadors with the recruitment of Cindy Crawford in the Nineties. Hublot was next, which Biver still oversees along with Tag Heuer, where he directed the launch of the first smartwatch from a luxury Swiss watch brand.



Biver’s recent focus has been the smallest of the LVMH watchmakers, Zenith. The 152-year-old luxury watch brand just developed a new oscillator to replace a system that uses dozens of components, challenging three centuries of tradition. The brand inserted it into a new model called Defy Lab, making only ten watches as it gears up for serial production of the monocrystalline silicon invention.
He spoke to WWD in his sparse modern office at the luxury behemoth’s Avenue Montaigne headquarters in Paris, stressing the importance of being disruptive, listening to younger generations and adhering to the existential philosophy of a brand. He also discussed influencers overtaking celebrities and explained why he’s wary when shopkeepers display their priciest timepieces in store windows.
With pointed hand raps and flashes of boyish enthusiasm, the watch industry maverick delivered his ideas in his signature style — that of a village wise man imposing order on a community’s disparate forces.
WWD: Can you explain your strategy for Zenith and talk about its challenges, starting with the name, which is associated with other companies?
Jean-Claude Biver: Having a name associated with other products is not a real problem in most countries but it remains an issue in the U.S. because Zenith was very well-known for electronic goods, radios and televisions.
Our heritage dates back to the 19th century when there was more of a regional outlook, and names weren’t protected in other countries. So it’s a problem, but not out of the ordinary and not too important.
On the other hand, the notoriety of the brand is weak, because it is a small brand. The smaller you are, the less well-known you are, in general. Take one of the best exceptions: Ferrari. It’s an example of a company with notoriety that is a thousand times more important than its sales.
With Zenith, we’re small and we don’t have much notoriety. Furthermore, its key product over the years, from the 20th century, was the El Primero. There are people who know the El Primero better than Zenith.
We are in the process of rebuilding and giving new impetus to Zenith. Little by little, as we add substance, creativity and innovation, we will compensate for shortfalls in notoriety.
Vision is very important for me, a vision that builds on the past. I don’t want a break from the past, I want continuity. Zenith will build on its history, but we will certainly not repeat it.
If you were to wake up, say, one of the greatest watchmakers in the world, Abraham-Louis Breguet and pull him out of his grave, do you think he would redo things as he did in 1795? Never! He would use the century he has woken up to. He would say, “Wow, you have microscopes! How extraordinary! You have new materials.” He would make use of everything our century has to offer to pursue his art. He would never repeat the past.
Here lies a great temptation: When you restructure a very old business, a very rich one, it’s tempting to redo the past.
WWD: How do the three different watch brands fit together at LVMH?
J.C.B.: Zenith is the future of traditional watchmaking. Accessible, which, in the watchmaking tradition means it’s already relatively expensive. The average price of a Zenith watch is 7,200 euros; Tag Heuer is around 2,800 euros, and Hublot is around 20,000 euros.



The three brands are extraordinarily different because they are positioned at completely different levels in terms of clientele, prices, distribution policies, marketing and message. Someone could do marketing for the three without getting it wrong because they are so different there will be no overlap.
If someone offers to make a connected watch for Zenith, it’s easy to say no because the message of Zenith is the future of tradition. This is not technology, because technology means obsolescence. Color televisions made black-and-white TV sets obsolete. Three-dimensional television will render today’s color television obsolete. Technology advances through what it kills off.
Art on the contrary, is eternal. Mozart’s art remains, Picasso’s art remains. Art brings eternity, technology brings obsolescence, Zenith is the future of tradition, so I won’t go for the connected watch model.
When each brand has defined its message, its existential philosophy, the reason why it exists, it becomes very easy to say yes that’s for me, or no, that’s not for me.
I believe that a brand, if it doesn’t have a message, it doesn’t have a reason to exist. If I say Hublot exists because it makes nice watches and good-quality watches, and because it’s Swiss, that’s not a reason. Anyone can say that.
Hublot exists because it’s the art of fusion. Fusion, which is the marriage of opposites. It’s Hublot that marries gold with rubber. That is disruptive. Before Hublot, rubber was never mixed with gold. In countries like Indonesia, India, or even China, they say what? I’m going to buy a watch that costs a million dollars and it has rubber straps, like a Swatch? No! That’s disruption.
WWD: Are you concerned that the middle-level price range might be challenging at a time when higher-end and lower-end goods seem to be performing better?
J.C.B.: No, thanks to Apple. Because people are wearing Apple, they have something on their wrists. Selling a watch to someone who already has a watch on their wrist, even if one might say it’s not a watch, it’s still a watch. Because you can’t say it’s a bracelet — it wouldn’t have any information.
WWD: What is the definition of a watch today?
J.C.B.: A watch is a tool that provides information that is worn on the wrist. There are two types: a pocket watch, which is a system of information that is kept in the pocket and a watch with a bracelet, that is worn on the wrist.
Whether the system of information gives time or the moon phases, or the day, the month, the date, or text messages, it’s the same thing, it’s just the information that’s different.
For me, an Apple watch is a watch.
As I understand it, Apple will sell 20 million Apple watches a year. They are promoting wearing something on the wrist. Perhaps one out of a hundred Apple consumers will say to themselves, I’d like a real watch, or I’d like an eternal watch, here, I’ve got technology, but perhaps for my 50th or 40th birthday, I’d like something I can wear, not every day, that could remain in my family, that I could give to the kids.
So indirectly, the watchmaker gets promoted through the Apple watch.
WWD: Two years after launching the Tag Heuer connected watch, can you say how it’s doing and share what you’ve learned from the project?
J.C.B.: The connected watch today sells well and has become a bestseller of the Tag Heuer collection. Not in terms of sales but in terms of quantity. It’s not the biggest in terms of sales because it’s a watch that’s not very expensive. It still costs around 1,600 euros, but, compared to the brand’s average price of 2,800 euros, it’s clearly entry price.
Given that it’s the watch we sell the most, I consider it a success.
It is also helped make the brand image younger, much more cool and geared toward technology. And this is as important as the sales.
WWD: How important was it for you to be the first watch brand to jump into smartwatches? Was it a risky move?
J.C.B.: I want to be the first, different and unique. Always. If I am the first, different and unique, in general, I won’t lose.
Of course, if I am not coherent, if I’m the first high-end, traditional brand, doing connected watches, for Zenith, for example, then there’s no point in being the first, different and unique.
If you were to do a connected watch for Hublot, the risk would be major. I would never have considered it, or even for Zenith. Never. It’s as if you offered me a pizza in a 3-star restaurant.
WWD: Is there anything you would have done differently?
J.C.B.: We underestimated the sales, so with the first watch, we missed the sales potential because we hadn’t prepared the right quantity. We had the music playing, lots of music, but then we couldn’t deliver. We got there when the music was over, the drumroll had ended. So we missed the synchronization between delivery and the launching, the advertising, and so forth.
WWD: What is your strategy for appealing to younger generations?
J.C.B.: Tag Heuer is enormously appealing to Millennials. This is why Tag Heuer teamed up with a street painter called Alec Monopoly; Cara Delevingne; Bella Hadid, and Martin Garrix, the DJ.
Zenith doesn’t speak to Millennials. Zenith speaks to young people, between 35 and 45 who are a bit fashionable, who like polished Berluti shoes, who perhaps like old motorcycles.
And then Hublot, it’s [Floyd] Mayweather who’s wearing a Hublot belt with his shorts. It’s soccer. Hublot is Ferrari, we have a big contract with Ferrari. Hublot speaks more to young millionaires.
We are looking for young people who represent the trends of today, but we are also looking for people who manage to influence young people today. The influencer is as important as an ambassador. The ideal is an ambassador that has a lot of notoriety and is very influential. There are ambassadors that have a lot of notoriety, that everyone knows but they influence no one.
So, 20 years ago, we looked especially for celebrities and today these influential people count more than the celebrities.
I listen to a sort of mini-advisory board with an average age of 16. And I have five children. I listen to my 17-year-old. And the 37-year-old, I don’t listen to anymore — well, not for this. Because he is already of a different generation, 20 years difference is the gap of a generation.
My son Pierre, who’s 17, he’s the one who told me Cara Delevingne, three years ago. She was sitting in the Nobu restaurant in London. I said, “Which one is she?” He had to tell me, “She’s the one all the way to the right.” I said, “Oh really? Why her?” “Because she’s influential.”
When you are 69, how do you expect to remain young? I cannot stay young myself, but I can remain young by what I learn.
You have to be humble, curious and listen. And learn. If you have that, you are young. That’s the recipe for youth. It’s not plastic surgery. It’s an attitude, worth all the surgery in the world, it costs less and it won’t disfigure you.
On the 22nd of December, I went to Tokyo with my son. My wife asked me, “what are you going to do, you’ve been going to Tokyo for 40 years? You know Tokyo.” I said, “no, I know my Tokyo.” It’s as if I said I know Paris because I go to the Place Vendôme, the Champs-Elysées and the Avenue Montaigne. But these young people, are they going to the Avenue Montaigne? Do they go to the Place Vendôme? If I want to know the Paris of the Millennials, I can’t know it myself so I have to take a young person and ask them.
So I discovered a new Tokyo. And I learned. We reversed our roles, and that’s completely normal.
WWD: Has the watch industry emerged from the crisis?
J.C.B.: Probably, at least it’s going to come out if it hasn’t already. The world economy is doing better and that clearly will have an effect on luxury.
There was the problem with China and the watch sector because of all the gifting. At first [anticorruption measures] caused a drop in sales but then it cleaned out the market. The market has become more real, healthier, more stable.
Lining up all of these elements, one after the other, means that today we can say the watch industry will, or has, exited the crisis.
WWD: What do you look at for signs of the industry’s health?
J.C.B.: When you’re in a town and you look at the store windows from the outside, you can immediately see the health of the brands. We were seeing watches of high value in the window. Well, normally when it comes to watches of high value, you’ve got one or two that you only show to special clients. That’s my indicator, the sell-out. When sell-out is not good, retailers try to show everything they have in the window. But when everything’s going well, they’ll say to the client: “I have something special for you, something very rare, look! I only have one. The next one I’ll have in four months.”
WWD: Did you have any memorable early jobs? Is it true that you were once a postal worker?
J.C.B.: I worked every night from eight at night until five in the morning. In the daytime I studied. I wanted independence. There were four of us living in an apartment, so I was living in a sort of mini-community and I adhered to the hippie philosophy. I never lost my hippie mentality, in fact. I lost my hair but I never lost my romanticism, my sense of sharing. I didn’t lose my respect for nature, we ate whole grain rice, I didn’t smoke weed, but being a hippie is not a question of drinking or smoking, it’s an existential philosophy.
I worked all night at the post office because I was sturdy and I earned money and that allowed me to be a student with money.
I didn’t want to stay with my parents. And if you’re not with your parents and your parents don’t give you money, well you have one possibility: you quit studying and work. Or you stay at home and study. I said: I’m leaving, I’m studying and I’m working.
I was as the post office at the train station and we had to pull out the postal bags from the trains and replace them with new bags. We worked at night because that’s when the freight trains circulated in Lausanne [Switzerland]. Paris Match came on Thursdays — those bags were heavy because the glossy paper weighed more than newspapers.
WWD: What professional accomplishment would you like people to remember the most?
J.C.B.: My contribution to the development of watchmaking. It would be a dream to be remembered for what I’ve done for my brands. For Blancpain, yes, that initiated the renaissance of the art of watchmaking.

*STATES TARGET MYLAN'S MALIK IN GENERIC DRUG-COLLUSION PROBE

*STATES TARGET MYLAN'S MALIK IN GENERIC DRUG-COLLUSION PROBE
15:56:53 WASHINGTON, Oct 31 (Reuters) - Forty-six U.S. state attorneys general will seek to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG's NOVN.S generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd SUN.NS, people familiar with the matter said.

The original complaint, being litigated in federal court in Pennsylvania, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices.

In the amended complaint, the number of generic drug manufacturers named goes from six to 18, including Endo International PLC's ENDP.O unit Par Pharmaceutical, Dr. Reddy's Laboratories, Apotex, Glenmark Generics Ltd GGLN.NS and Lannett Company Inc LCI.N, the sources said.

Big players in the multi-billion dollar generic drug industry stand accused of conspiring to boost prices in a marketplace in which consumers assume they are buying lower-priced versions of widely used drugs.

Two senior executives from drug companies alleged to have engaged in the illegal conduct are also being sued, the sources said.

Connecticut Attorney General George Jepsen is leading the coalition of states. A news conference announcing the expanded lawsuit has been scheduled for 11 a.m. (1500 GMT) in Connecticut.

The new complaint will address the relationships between such parties as wholesalers, distributors, large pharmacies and supermarkets, the sources said, adding that it will also cover the agreements with manufacturers to keep prices high.

The previous lawsuit, filed in December, had focused on Mylan NV MYL.O, Teva Pharmaceutical Industries Ltd TEVA.TA and four other companies. It had centered on just two medicines: a delayed-release version of a common antibiotic, doxycycline hyclate; and glyburide, an older drug used to treat diabetes. (Full Story)

The amended complaint expands the number of drugs to include glipizide-metformin and glyburide-metformin, which are among the most commonly used diabetes treatments, the sources said.

Others include: acetazolamide, which is used to treat glaucoma and epilepsy; the antibiotic doxycycline monohydrate; and the blood pressure medicine fosinopril. Others are the anxiety medicine meprobamate and the calcium channel blocking agent nimodipine, the sources said.